ã¨ãã©ã¦ã¤ã«ã¹ç ï¼ã¨ãã©åºè¡ç±ï¼ãæ£ããæããããã«ï¼ï¼ï¼ââçºçãã¦ãªã人ããã¯ææããªãã£ã¦æ¬å½ï¼
ã¤ãã«æ¥æ¬ã§ãçãä¾ãã¨ããBSL4æ½è¨ç¨¼åããããã¨ãã対岸ã®ç«äºãã©ãã©ãè¿ã¥ãã¦ããããã«æãããã¾ãããå½ããã°ã¯ããããã¦ã¤ã«ã¹çè«æç´¹ä»ããã°*1ã§ã¯ããã¾ãããããããæã«æ å ±çºä¿¡ãã¦ããã ãã¼ï¼ã¨ãããã¨ã§ãä»åãå¼ãç¶ãã¨ãã©ã£ã¦ã¿ã¾ãããã
ä»åã¯ãã¨ãã©ã®åºç¤ç¥èã¨ãã¦è¯ãè¨ãããï¼ããã¦ãä¸å®ã«ãªã£ã¦ãã人ãå¤ãã ããã¨æãããï¼ãæ½ä¼æéã¯ã¦ã¤ã«ã¹ãæåºããªããã¨ããè¨èª¬ã«ã¤ãã¦ãè«æãç´¹ä»ãã¦ã¿ããã¨æãã¾ãã
ãã®åã«ä¸ã¤ã ããã¨ãã©ã®åºè¡ã¯ä»ã®åºè¡ç±ã¦ã¤ã«ã¹ã«æ¯ã¹ã¦ããå®ã¯ãããªã«æ¿ããããã¾ãããç²èããã®åºè¡ãç®ä¸åºè¡ãã»ã¨ãã©ã§ããããªãé¼»è¡ã©ã°ã¼ã£ï¼åè¡ãã¼ã¼ã£ï¼ã¨ããç®ããè¡æ¶ã ãã¼ã£ï¼ã¿ãããªãã¨ã¯èµ·ãã¾ããã®ã§ãããããã®ã¯ãã£ã¯ã·ã§ã³ã®ä¸ã§ã楽ãã¿ãã ããã
ã¾ãã¯こちらの論文ãçé èè
ã¯æ¥æ¬äººã
Host response dynamics following lethal infection of rhesus macaque... - PubMed - NCBI
ãµã«ã«ã¨ãã©ãå®é¨ææããã¦ãããã¼ããªãã©ã¡ã¼ã¿ã¼ãããã§ããã£ã¦å ·åã«è§£æããè«æã§ãããµã«ã§ã®ã¨ãã©ç±çç¶ã¯ãçºç±ã¨ç²èããã®åºè¡ãç®ä¸åºè¡ã§ãããããå§ã¾ãã®ãææ2-3æ¥å¾ãã¦ã¤ã«ã¹ãè¡ä¸ã«æ¤åºã§ããã®ãã»ã¼åãã¿ã¤ãã³ã°ã§ããããã ã確èªããã人ã¯Fig. 1Aã¨1Eï¼Viremiaï¼ã ãè¦ããããããããªãã§ããããããµã¤ãã«ã¤ã³ãååºå åãªã©ã®ç¥èããã人ã¯ä»ã®å³ãè¦ãã¨é¢ç½ãã¨æãã¾ããã¦ã¤ã«ã¹ãå¢æ®ããã¿ã¤ãã³ã°ã§ä¸ãã£ããä¸ãã£ãããæ«æã«ã¯ãããããµã¤ãã«ã¤ã³ã¹ãã¼ã ãèµ·ãã¦ã¾ãã
次の論文はこちらãZMAbã§ãµã«ãæ²»çããè«æã§ãããä»åè¦ãã®ã¯æ²»çã«å¤±æãã2é ï¼B2ã¨B3ï¼ã¨ã³ã³ããã¼ã«ã®1é ï¼C1ï¼ã®æ°åã§ãã
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Table 1ãè¦ã¦ã¿ã¾ããããããã¯ãçµæçã«å£è ãé¼»è ãç´è ¸ããããã®ã¬ãã液ãRT-PCRã«ããã¦ã¦ã¤ã«ã¹æåºã®æç¡ãè¦ãå®é¨çµæã§ããNDã¯èª¿ã¹ã¦ãªãããã¼ãã¯æ¤åºéç以ä¸ãæ¤åºéçã¯1 PFU/mLãããã¯ããã¼ãã§ããã°ã¦ã¤ã«ã¹ã¯ããªãã¨è¨ã£ã¦ããããããã®æ°åã§ããFig. 2ã¨è¦æ¯ã¹ãªããèªãã¨ãã¨ãã©ç±ã®çç¶ãé²è¡ãå®æ¥½æ®ºããããå¾ãªãã£ãB2ãB3ãC1ã®3é ã¨ããå®æ¥½æ®ºç´åï¼ï¼å¤è¦ãããã¦èª¿åããããæªãããªç¶æ ï¼ã«ãªããªãã¨ã¬ãã液ããã¦ã¤ã«ã¹ãæ¤åºã§ããªããã¨ãåããã¾ãã
ã¡ãªã¿ã«ãæ²»çã§ãããµã«ã®ã¬ãã液ããã¯ã¦ã¤ã«ã¹ãã¾ã£ããæ¤åºã§ãã¦ã¾ããããã¦ãã§ããã
最後の論文はこちらããã¾ãçã«å復æã®ã話ã
Assessment of the risk of Ebola virus transmission from bodily flui... - PubMed - NCBI
æ²»çããå¾ãã©ã®ä½æ¶²ã«ã©ããããã®æéã¦ã¤ã«ã¹ãæåºãããããã調ã¹ãè«æãæ¯ä¹³ã精液ã«ããé·æéæåºããããã¨ãã話ã¯ãã®è«æãåºå ¸ã§ãããããä½æ¶²ã®ç¨®é¡ã«ãä¾ãã¾ãããããã1é±éç¨åº¦ãé·ãã¦1ã¶æ以ä¸ã¦ã¤ã«ã¹ãæåºãããã¨ãããã¨ã§ãæ²»çããæ£è ã解æ¾ãããã¾ã§ã«ã¯ãããããã®æéãè¦ç©ãããªãã¨ãããªãã®ã§ãã
ã¾ã¨ããã¨ãæ®éã®äººã触ããå±éºã®ãããä½æ¶²ãã§ããã¨ããã®å¾æ¶²ãææ³ç©ããã¯ãçç¶ãåºãã¾ã§ã¦ã¤ã«ã¹ã¯æ¤åºã§ãã¾ãããçç¶ãåºå§ããã¨ãè¡ä¸ã«ã¯å¤§éã®ã¦ã¤ã«ã¹ãæ¾åºããã¦ããã®ã§ãè¡ãæ··ãã£ãä½æ¶²ã«ã¯ç¹ã«æ°ãã¤ãã¾ããããã¨ããã¨ããã§ãããããå復ããæ£è ããã¯ãã°ããã¦ã¤ã«ã¹è£½é æ©ã«ãªã£ã¡ããã®ã§ãç³ã訳ãªãã§ããããã£ããæ¤æ»ã§ç¢ºå®ããã¾ã§ã¯éé¢ã§ãã
ã ããå®å¿ã ãã¨ããã¤ããã¯æ¯é ããã¾ãããä¼ãããã®ã¯ããããã£ãå®é¨çãªç¥è¦ã«å ããéå»ã®ã¢ã¦ããã¬ã¤ã¯ç¾å ´ã§ã®çµé¨ã®èç©ããããæ½ä¼æã®æ£è ã¨ã®ï¼é常ã®ç¯å²ã§ã®ï¼æ¥è§¦ã¯åé¡ãªããã¨ãã話ã«ãªãããç¾å°ãã帰ã£ã¦ããå»çé¢ä¿è ã®éé¢ã¯ããã1æ¥2åã®æ¤æ¸©ã21æ¥ãã¨ãã話ã«ãç¹ãã£ã¦ãããã¨ãããã¨ã§ããæºå¡é»è»ã®è©±ã«ã¯ã¡ãã£ã¨é£å·æ°å³ãªãã§ããããã¨ãããããã ï¼
*1:ããã表ç¾ãæ°ã«å ¥ããªãã£ããããããâ